Patient Enrollment and Data Analysis

$285,709U54FY2015HLNIH

University Of Utah, Salt Lake City UT

Investigators

Andrew Scott Weyrichcontact Guy A. Zimmerman

Linked publications & trials

Paper 38212381 Paper 38156445 Paper 36325902 Paper 35316657 Paper 33910093 Paper 33360636 Paper 33297754 Paper 32129085 Paper 31852401 Paper 31800959 Paper 31311815 Paper 31140293 Paper 30931337 Paper 30765335 Paper 30723081 Paper 30600428 Paper 30580566 Paper 30567722 Paper 30282800 Paper 29981265 Paper 29758998 Paper 29575487 Paper 29553813 Paper 29386381 Paper 29301786 Paper 29258393 Paper 29117572 Paper 29058688 Paper 28861436 Paper 28775073 Paper 28771279 Paper 28746873 Paper 28663252 Paper 28601834 Paper 28500171 Paper 28202460 Paper 27913489 Paper 27848259 Paper 27712881 Paper 27648522 Paper 27629384 Paper 27599294 Paper 27270163 Paper 27265506 Paper 27112789 Paper 27054505 Paper 26936507 Paper 26866684 Paper 26848712 Paper 26773046 Paper 26751613 Paper 26744461 Paper 26618986 Paper 26537353 Paper 26476238 Paper 26320940 Paper 26285587 Paper 26253611 Paper 26241060 Paper 26153425 Paper 26149034 Paper 26148065 Paper 26111103 Paper 26004364 Paper 25887317 Paper 25807284 Paper 25791433 Paper 25705885 Paper 25700592 Paper 25657313 Paper 25657311 Paper 25566264 Paper 25540039 Paper 25535334 Paper 25533967 Paper 25529920 Paper 25471925 Paper 25433511 Paper 25257092 Paper 25061876 Paper 25010915 Paper 24930970 Paper 24904119 Paper 24895453 Paper 24763461 Paper 24755410 Paper 24651796 Paper 24638185 Paper 24583251 Paper 24578465 Paper 24512275 Paper 24458711 Paper 24444445 Paper 24440566 Paper 24319095 Paper 24163053 Paper 24140114 Paper 24115071 Paper 24057673 Paper 24052497

Abstract

PROJECT SUMMARY (See instructions): The primary responsibility of the Patient Enrollment and Data Analysis Core (Core B) is to identify and recruit healthy lean control subjects as well as patients with type 2 diabetes and obesity for Projects 1-4 and provide specialized data analysis support for the University of Utah Molecular Medicine Translational Research Center in Thrombosis (U2M2-TRCT). A team of investigators with expertise in thrombosis and metabolic syndromes will lead Core B. This core also includes a clinical coordinator, database manager, and investigators with experience in statistics and bioinformatics. Core B will directly interact with Core C regarding isolation of human platelets from patients with metabolic syndromes and provide support for all four research projects. Patients enrolled through Project 3 will be identified and recruited by Core C using successful methods described in the Core description. The Core will utilize the University of Utah Clinical Center in Translational Science (CCTS) to enhance patient enrollment and study initiation. Core B will be responsible for entering patient data and management of the U-STAR (The Utah Study of Translational Science And Research Registry) database. In addition to recruiting, enrolling, and managing data, Core B will provide statistical and bioinformatics support for all of the projects. The statistics wing will provide sample size and power calculations, assist with study design, and analyze experimental data. The bioinformatics arm will provide support for the next-generation RNA-sequencing studies proposed by U2M2-TRCT investigators. This includes data interpretation, statistical support, and software development. The services provided by Core B, which is centrally located and readily available to all U2M2-TRCT participants, will ensure that enrollment goals are met and exceeded and that data analysis occurs seamlessly within the program.

View original record on NIH RePORTER →